How do defective drugs get on the market?
Get Your Free Claim Review
Unfortunately, many drug manufacturers, driven by money, will streamline test information and downplay or conceal adverse side effects found in their studies in an effort to speed up FDA approval. Furthermore, once the FDA is reviewing the drug, they fail to conduct adequate follow-up research or don’t have enough time to perform a rigorous screening of the product, which may lead to the approval of defective drugs. Many researchers who publish the findings of clinical drug trials are not given all the data available, which can lead to a skewed safety profile about the drug.